Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

273.53 -2.74 (-0.99%)

Streaming Delayed Price Updated: 10:38 AM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Why Natera (NTRA) Stock Is Up Today

June 24, 2026

What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 7.7% in the morning session after the company announced its Signatera test rece...

Via StockStory

Topics Artificial Intelligence

1 Healthcare Stock for Long-Term Investors and 2 We Turn Down

June 16, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...

Via StockStory

1 Cash-Heavy Stock on Our Buy List and 2 We Avoid

June 15, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...

Via StockStory

Topics Retirement

2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down

June 08, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

Via StockStory

Natera (NTRA) Q1 Revenue Beat Overshadowed by EPS Miss and Operating Losses ↗

May 07, 2026

Via Chartmill

Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia) ↗

June 03, 2026

The famous hedge fund manager seems to have found a hidden gem outside of the market's most popular stock picks.

Via The Motley Fool

NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million ↗

May 30, 2026

MercadoLibre delivers e-commerce and fintech solutions across Latin America, leveraging an integrated digital ecosystem for regional growth.

Via The Motley Fool

Topics Regulatory Compliance

1 Mid-Cap Stock with Exciting Potential and 2 That Underwhelm

May 19, 2026

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...

Via StockStory

5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call

May 14, 2026

Natera’s first quarter was marked by robust top-line growth and higher-than-expected sales volumes, but the market responded negatively due to a wider-than-a...

Via StockStory

Topics Earnings

Why Natera (NTRA) Shares Are Plunging Today

May 08, 2026

What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA). fell 12.2% in the afternoon session after the company reported mixed first-quarter 202...

Via StockStory

Topics Artificial Intelligence Economy

Natera Q1 Earnings Call Highlights ↗

May 08, 2026

Natera (NASDAQ:NTRA) reported first-quarter 2026 revenue of $697 million, up 39% year over year, as the company delivered more than 1 million total units in a single quarter for the first time. Chief...

Via MarketBeat

Topics Earnings

NTRA Q1 Deep Dive: Robust Volume Growth and Product Expansion Shape Outlook

May 08, 2026

Genetic testing company Natera (NASDAQ:NTRA). reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 38.8% year on year to $696....

Via StockStory

Natera NTRA Q1 2026 Earnings Call Transcript ↗

May 07, 2026

Natera NTRA Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Natera’s (NASDAQ:NTRA) Q1 CY2026 Sales Top Estimates

May 07, 2026

Genetic testing company Natera (NASDAQ:NTRA). announced better-than-expected revenue in Q1 CY2026, with sales up 38.8% year on year to $696.6 million. Its GA...

Via StockStory

What To Expect From Natera’s (NTRA) Q4 Earnings

May 05, 2026

Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results this Thursday afternoon. Here’s what to expect. Natera beat analysts’ reven...

Via StockStory

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)

April 20, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence

3 Reasons We’re Fans of Natera (NTRA)

April 20, 2026

Natera has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6%. The stock now trades at $208.20, marking a 10.5% gain....

Via StockStory

Topics Stocks

Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know

April 17, 2026

What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...

Via StockStory

Topics Economy Government Stocks

1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm

April 15, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

April 09, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

3 Reasons NTRA Has Explosive Upside Potential

April 09, 2026

Even during a down period for the markets, Natera has gone against the grain, climbing to $211.23. Its shares have yielded a 22.1% return over the last six m...

Via StockStory

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Government Stocks

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)...

Via MarketMinute

Topics Supply Chain

1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds

March 20, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

1 Cash-Heavy Stock to Target This Week and 2 We Question

March 19, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Vera Therapeutics develops clinical-stage therapies for serious immunological diseases, with a lead candidate targeting kidney disorders.

Via The Motley Fool

Topics Regulatory Compliance

This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗

March 16, 2026

Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology clients worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

3 Growth Stocks to Add to Your Roster

March 16, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

Via StockStory

3 Market-Beating Stocks to Target This Week

March 13, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.